112
Participants
Start Date
October 26, 2022
Primary Completion Date
April 4, 2024
Study Completion Date
April 4, 2024
AZD4831
AZD4831
Placebo
Placebo
Research Site, Ciudad de Buenos Aires
Research Site, Pilar
Research Site, Grålum
Research Site, København Ø
Research Site, København NV
Research Site, Gjøvik
Research Site, Køge
Research Site, Esbjerg
Research Site, Mar del Plata
Research Site, Aarhus N
Research Site, Torino
Research Site, Yonkers
Research Site, A Coruña
Research Site, Rozzano
Research Site, Milan
Research Site, Milan
Research Site, Lleida
Research Site, Madrid
Research Site, Pozuelo de Alarcón
Research Site, Morehead City
Research Site, Málaga
Research Site, Jacksonville
Research Site, Miami
Research Site, Lakeland
Research Site, Lakeland
Research Site, Santander
Research Site, Guadalajara
Research Site, Guadalajara
Research Site, Guadalajara
Research Site, Valencia
Research Site, Monterrey
Research Site, Monterrey
Research Site, Monterrey
Research Site, San Giovanni Rotondo
Research Site, Foggia
Research Site, Dallas
Research Site, Houston
Research Site, San Antonio
Research Site, Chandler
Research Site, Tucson
Research Site, Las Vegas
Research Site, Redondo Beach
Research Site, Montclair
Research Site, Chula Vista
Research Site, Orange
Research Site, Boca del Rio
Research Site, Stanford
Research Site, Catania
Research Site, CABA
Research Site, CABA
Research Site, CABA
Research Site, Ramos Mejía
Research Site, Roma
Research Site, Roma
Research Site, Cuauhtémoc
Research Site, Mexico City
Research Site, Mexico City
Research Site, Mexico City
Research Site, México
Research Site, Lørenskog
Research Site, Oslo
Research Site, Tromsø
Research Site, Lisbon
Research Site, Linköping
Research Site, Uppsala
Lead Sponsor
AstraZeneca
INDUSTRY